Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
Cellectis

November 2025

Cellectis Market Share Analysis for November 2025

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.
Year Founded1999
Employees201 - 500
Annual Revenue$25M - $50M
cellectis.com
Cellectis
Cellectis (including company regionals)
  • cellectis.com
    cellectis.com
See more website traffic and engagement information

Cellectis Revenue up to November 2025 is 25M - 50M

revenue generated by Cellectis top domains

Cellectis top domains revenue over 3 years

Revenue for Cellectis top domains

cellectis.comcellectis.com25M - 50M
See more with Sales Intelligence

Total visits to Cellectis's top domains

Understand Cellectis market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Cellectis's top domains

Analyze Cellectis engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Cellectis's top domains

See how Cellectis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Cellectis

These are the website technologies, by industry, used by Cellectis top domains

Payment & Currencies (22)

PayPal

PayPal

Advertising (5)

Google Adsense

Google Adsense

Widget (3)

reCAPTCHA

reCAPTCHA

Content Management System (2)

Drupal

Drupal

More Technologies

12

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Cellectis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCellectis Group attends event ASH 2025.Cellectis to present a development update for eti-cel at ASH 2025.
NewsFactor Bioscience Limited files suit against Cellectis Group.Factor Bioscience files complaint against Cellectis and AstraZeneca alleging infringement of foundational gene-editing patents.
NewsCellectis Group is developing life-saving cell and gene therapies.Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies.

See all Cellectis signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.